Robert E. Gagnon
Chief Financial Officer; Director · 6 filings · Latest: Sep 28, 2026
Bone Biologics Corp
HARVARD BIOSCIENCE INC
Opus Genetics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
IRD | Robert E. Gagnon | Chief Financial Officer | Sep 3, 2026 | Sale | $4.54 | 28,000 | $127.2K | 556,375 | |
IRD | Gagnon Robert E. | — | Sep 3, 2026 | Proposed Sale | $4.45 | 28,000 | $124.6K | — | |
IRD | Robert E. Gagnon | Chief Financial Officer | Jul 23, 2026 | Sale | $2.95 | 7,783 | $22.9K | 584,375 | |
IRD | Gagnon Robert E. | — | Jul 23, 2026 | Proposed Sale | $3.05 | 7,783 | $23.7K | — | |
VSTM | Gagnon Robert E. | — | Jul 23, 2026 | Proposed Sale | $5.89 | 31,924 | $188.0K | — | |
VSTM | Gagnon Robert E. | — | Jun 25, 2026 | Proposed Sale | $4.21 | 21,492 | $90.5K | — | |
VSTM | Gagnon Robert E. | — | May 27, 2026 | Proposed Sale | $4.36 | 20,103 | $87.6K | — | |
IRD | Robert E. Gagnon | Chief Financial Officer | Apr 23, 2026 | Sale | $5.18 | 7,842 | $40.7K | 592,158 | |
IRD | Gagnon Robert E. | — | Apr 23, 2026 | Proposed Sale | $5.18 | 7,842 | $40.7K | — |